Publications Office of the EU
Conclusion of a non-exclusive discount agreement pursuant to § 130a(8) SGB V on the active substance bimekizumab, ATC L04AC21 for the period 01.10.2024 - 30.09.2026 - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Conclusion of a non-exclusive discount agreement pursuant to § 130a(8) SGB V on the active substance bimekizumab, ATC L04AC21 for the period 01.10.2024 - 30.09.2026

Overview
  • Published
    19/08/2024
  • Deadline
    05/08/2026
  • Opening of tenders
    05/08/2026
  • Awarded
    01/10/2026
  • Today
    01/10/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
DAK-Gesundheit
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: DE600 Hamburg
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
1.00 EUR
Total final contract value (excluding VAT)
-1.00 EUR
Procedure details
Tender reference number
1004483 - Bimekizumab, ATC L04AC21
Description

Section 130a(8) SGB V enables health insurance funds and pharmaceutical companies to conclude framework discount contracts for the medicinal products to be supplied at the expense of the statutory health insurance funds. With regard to the relevant legal provisions on public procurement, a regular process of active substance-related, formal procurement procedures takes place by the DAK-Gesundheit in accordance with the regulations of Part Four of the GWB. For medicinal products to be specified by the tenderer in Annex 2 to the contract relating to the above-mentioned active substance, bimekizumab, ATC L04AC21, DAK-Gesundheit intends to conclude pharmaceutical discount contracts with all interested pharmaceutical companies until new pharmaceutical discount contracts enter into force. A discount agreement within the meaning of the approval model for the above-mentioned active substance enters into force for the first time on 1 October 2024 and ends on 30 September 2026. Irrespective of this, it automatically ends with the entry into force of the exclusive contract.

Submission Method
Electronic via:
https://www.dtvp.de/Satellite/notice/CXP4YM5H7A7
Tenders may be submitted
Electronic submission: required
https://www.dtvp.de/Satellite/notice/CXP4YM5H7A7
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
05/08/2026 12:01
Place of performance
DE Deutschland
DE600 Hamburg
CPV code

33600000 - Pharmaceutical products

Award method
Criterion:
Type: price
Description: 100% Preis
Weight (percentage, exact):
Estimated value
1.00 EUR
Final contracted value
-1.00 EUR
Award of contract
Official name: Paranova Pack A/S
Postal address:
Town: Herlev
Postal code: 2730
Country:
Official name: UCB Pharma GmbH
Postal address:
Town: Monheim
Postal code: 40789
Country:
Official name: Originalis B.V.
Postal address:
Town: Amsterdam
Postal code: 1114 AB
Country:
Official name: EurimPharm Arzneimittel GmbH
Postal address:
Town: Saaldorf-Surheim
Postal code: 83416
Country:
Official name: Orifarm GmbH
Postal address:
Town: Leverkusen
Postal code: 51381
Country:
Official name: kohlpharma GmbH
Postal address:
Town: Merzig
Postal code: 66663
Country:
Official name: Abacus Medicine A/S
Postal address:
Town: Kopenhagen
Postal code: 1560
Country:
Official name: axicorp Pharma B.V.
Postal address:
Town: Den Haag
Postal code: 2585
Country:
Official name: CC Pharma GmbH
Postal address:
Town: Densborn
Postal code: 54570
Country:
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.